BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23289804)

  • 1. Genetic polymorphisms associated with retinal vein occlusion: a Greek case-control study and meta-analysis.
    Yioti GG; Panagiotou OA; Vartholomatos GA; Kolaitis NI; Pappa CN; Evangelou E; Stefaniotou MI
    Ophthalmic Genet; 2013 Sep; 34(3):130-9. PubMed ID: 23289804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of genetic polymorphisms and diabetes mellitus on the development of peripheral artery disease.
    Yalım Z; Tutgun Onrat S; Alan S; Aldemir M; Avşar A; Doğan İ; Onrat E
    Turk Kardiyol Dern Ars; 2020 Jul; 48(5):484-493. PubMed ID: 32633259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
    Cruciani F; Moramarco A; Curto T; Labate A; Recupero V; Conti L; Gandolfo GM; Balacco Gabrieli C
    Clin Ter; 2003; 154(5):299-303. PubMed ID: 14994919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
    Russo PD; Damante G; Pasca S; Turello M; Barillari G
    Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C; Hellstern P; Nägler DK; Kohnen T; Hattenbach LO
    Ophthalmic Genet; 2017; 38(5):413-417. PubMed ID: 28085526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels.
    Gori AM; Marcucci R; Fatini C; Gensini F; Sticchi E; Sodi A; Cappelli S; Menchini U; Gensini GF; Abbate R; Prisco D
    Thromb Haemost; 2004 Jul; 92(1):54-60. PubMed ID: 15213845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
    Gohil R; Peck G; Sharma P
    Thromb Haemost; 2009 Aug; 102(2):360-70. PubMed ID: 19652888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
    Jusić A; Balić D; Avdić A; Pođanin M; Balić A
    Med Glas (Zenica); 2018 Aug; 15(2):158-163. PubMed ID: 29703881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1, factor V, factor II and methylenetetrahydrofolate reductase polymorphisms in women with recurrent miscarriage.
    Pietropolli A; Giuliani E; Bruno V; Patrizi L; Piccione E; Ticconi C
    J Obstet Gynaecol; 2014 Apr; 34(3):229-34. PubMed ID: 24484533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
    Dodson PM; Haynes J; Starczynski J; Farmer J; Shigdar S; Fegan G; Johnson RJ; Fegan C
    Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab.
    Falvella FS; Cremolini C; Miceli R; Nichetti F; Cheli S; Antoniotti C; Infante G; Martinetti A; Marmorino F; Sottotetti E; Berenato R; Caporale M; Colombo A; de Braud F; Di Bartolomeo M; Clementi E; Loupakis F; Pietrantonio F
    Pharmacogenomics J; 2017 Jul; 17(4):331-336. PubMed ID: 27001121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in prothrombotic genes in young stroke patients in Greece: a case-controlled study.
    Ranellou K; Paraskeva A; Kyriazopoulos P; Batistatou A; Evangelou A; El-Aly M; Zis P; Tavernarakis A; Charalabopoulos K
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):430-5. PubMed ID: 25699610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombophilic gene polymorphisms and recurrent pregnancy loss in Greek women.
    Chatzidimitriou M; Chatzidimitriou D; Mavridou M; Anetakis C; Chatzopoulou F; Lialiaris T; Mitka S
    Int J Lab Hematol; 2017 Dec; 39(6):590-595. PubMed ID: 28603947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of methylenetetrahydrofolate reductase (A1298C and C677T) polymorphisms with retinal vein occlusion in Tunisian patients.
    Mrad M; Wathek C; Saleh MB; Baatour M; Rannen R; Lamine K; Gabsi S; Gritli N; Fekih-Mrissa N
    Transfus Apher Sci; 2014 Apr; 50(2):283-7. PubMed ID: 24440586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
    Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABO blood group but not haemostasis genetic polymorphisms significantly influence thrombotic risk: a study of 180 homozygotes for the Factor V Leiden mutation.
    Procare-GEHT Group
    Br J Haematol; 2006 Dec; 135(5):697-702. PubMed ID: 17107352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective case-control study analyzes 12 thrombophilic gene mutations in Turkish couples with recurrent pregnancy loss.
    Yenicesu GI; Cetin M; Ozdemir O; Cetin A; Ozen F; Yenicesu C; Yildiz C; Kocak N
    Am J Reprod Immunol; 2010 Feb; 63(2):126-36. PubMed ID: 19906129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
    Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: a meta-analysis.
    McGimpsey SJ; Woodside JV; Cardwell C; Cahill M; Chakravarthy U
    Ophthalmology; 2009 Sep; 116(9):1778-1787.e1. PubMed ID: 19729099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilioretinal artery: Vasculogenesis might be promoted by plasminogen activator inhibitor-1 5G allele.
    Yilmaz S; Ardagil A; Akalin I; Altinel MG; Dag Y; Kurum E; Koyun E; Ari Yaylali S; Bayramlar H
    Ophthalmic Genet; 2017; 38(5):428-433. PubMed ID: 28145780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.